Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
NVIDIA (NVDA.O) guides FY2027 Q3 revenue at $108.0 bln, versus market expectation of $104.2 bln.
2026-08-27
NVIDIA (NVDA.O) guides FY2027 Q3 revenue at $108.0 bln, versus market expectation of $104.2 bln.
Back
Other News
2026-08-26
Australia's building completions grew at an annualized rate of 2.7% in the second quarter, compared with 6.3% in the previous quarter.
Australia's building completions grew at an annualized rate of 2.7% in the second quarter, compared with 6.3% in the previous quarter.
2026-08-26
NVIDIA (NVDA.O) will report Q2 after the US close on Wednesday. FactSet’s survey of analysts projects revenue $92.27 bln vs $46.74 bln a year earlier; net income $51.55 bln ($2.11 per share) vs $26.42 bln ($1.08) last year. Analysts expect adjusted E
NVIDIA (NVDA.O) will report Q2 after the US close on Wednesday. FactSet’s survey of analysts projects revenue $92.27 bln vs $46.74 bln a year earlier; net income $51.55 bln ($2.11 per share) vs $26.42 bln ($1.08) last year. Analysts expect adjusted EPS $2.09 vs $1.05 a year earlier. NVIDIA is increasingly positioning itself beyond a chip supplier toward financing broader AI infrastructure; that financing expansion and other long-term themes are likely to drive investors focus. Morgan Stanley and JP Morgan analysts say the key watchpoints are NVIDIA’s financing footprint, China exposure, semiconductor competition risk, future gross margins, and the ramp schedule for the Vera Rubin chip. Rubin is unlikely to produce a material contribution before the quarter beginning in October. Benchmark analyst Cody Acree said, given already-elevated expectations investors will need to see incremental evidence beyond another routine beat and guidance raise.
Chat with us
, powered by
LiveChat